Skip to main content

$0.125 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
2 July 2025 at 10:12am
Register to track EMD and receive email alerts.
Subject
EMD Ann: Application for quotation of securities - EMD

EMD Ann: Appendix 4C - Quarterly

EMD Ann: Letter to Shareholders - General Meeting

EMD Ann: Notice of General Meeting/Proxy Form

EMD Ann: Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD

EMD Ann: Notification regarding unquoted securities - EMD

EMD Ann: Proposed issue of securities - EMD

EMD Ann: Emyria appoints Sixty Two Capital as corporate advisor

EMD Ann: Notice under section 708A(5)(e) of the Corporations Act

EMD Ann: Application for quotation of securities - EMD

EMD Ann: Change of Registry Address

EMD Ann: Emyria adds wearables to psychedelic-assisted therapy trials

EMD Ann: Trading Halt

EMD Ann: Pause in Trading

EMD Ann: Positive animal data for Emyrias ultra-pure CBD capsule

EMD Ann: Positive initial MDMA-analogue screening results

EMD Ann: Change of Director's Interest Notice KS

EMD Ann: Application for quotation of securities - EMD

EMD Ann: Notice under section 708A(5)(e) of the Corporations Act

EMD Ann: Application for quotation of securities - EMD

EMD Ann: Application for quotation of securities - EMD

EMD Ann: Initial Director's Interest Notice KS

EMD Ann: Emyria Appoints Global Pharma Expert Dr Karen Smith to Board

EMD Ann: Emyria Anoints Global Pharma Expert Dr Karen Smith to Board

EMD Ann: Change in substantial holding SW

EMD Ann: Change in substantial holding MW

EMD Ann: Change in substantial holding MT

EMD Ann: Change in substantial holding CD

EMD Ann: Becoming a substantial holder TAT

EMD Ann: Notification regarding unquoted securities - EMD

EMD Ann: Application for quotation of securities - EMD

EMD Ann: Notice under section 708A(5)(e) of the Corporations Act

EMD Ann: Emyria receives $1,162,000 R&D Tax Incentive Refund

EMD Ann: Application for quotation of securities - EMD

EMD Ann: Proposed issue of securities - EMD

EMD Ann: Emyria Welcomes Tattarang as Strategic Investor

EMD Ann: Trading Halt

EMD Ann: Results of Meeting

EMD Ann: Notification regarding unquoted securities - EMD

EMD Ann: Appendix 4C - Quarterly

EMD Ann: MDMA Analogue Development Milestone

EMD Ann: Notification of cessation of securities - EMD

EMD Ann: Notification of cessation of securities - EMD

EMD Ann: Notification of cessation of securities - EMD

EMD Ann: Notification regarding unquoted securities - EMD

EMD Ann: Emyria selected to join Palantirs Foundry Builders Program

EMD Ann: EMD Welcomes TGA-Commissioned Report on MDMA and Psilocybin

EMD Ann: Annual Report to shareholders

EMD Ann: Appendix 4G

EMD Ann: Letter to Shareholders - Annual General Meeting

Register to track EMD and receive email alerts.

Similar Companies

EHE
JHC
MVF
ONT
PSQ
REG
RHC
VRT